The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 4,012 | 400,000 | SH | OTR | 1 | 400,000 | 0 | 0 | |
| ALPHABET INC | CAP STK CL C | 02079K107 | 38,460 | 400,000 | SH | OTR | 1 | 400,000 | 0 | 0 | |
| APOLLO GLOBAL MGMT INC | COM | 03769M106 | 32,085 | 690,000 | SH | OTR | 1 | 690,000 | 0 | 0 | |
| BRP GROUP INC | COM CL A | 05589G102 | 23,715 | 900,000 | SH | OTR | 1 | 900,000 | 0 | 0 | |
| CARDLYTICS INC | NOTE 1.000% 9/1 | 14161WAB1 | 3,035 | 5,000,000 | PRN | OTR | 1 | 5,000,000 | 0 | 0 | |
| LEAD EDGE GROWTH OPRTUNTS LT | UNIT 04/01/2026 | G54085124 | 3,960 | 400,000 | SH | OTR | 1 | 400,000 | 0 | 0 | |
| LGI HOMES INC | COM | 50187T106 | 3,255 | 40,000 | SH | OTR | 1 | 40,000 | 0 | 0 | |
| NVR INC | COM | 62944T105 | 19,935 | 5,000 | SH | OTR | 1 | 5,000 | 0 | 0 | |
| VY GLOBAL GROWTH | UNIT 99/99/9999 | G9444H126 | 8,526 | 850,000 | SH | OTR | 1 | 850,000 | 0 | 0 | |